Macquarie Group’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.6M | Sell |
80,000
-109,793
| -58% | -$3.57M | ﹤0.01% | 1148 |
|
|
2025
Q1 | $7.17M | Sell |
189,793
-58,241
| -23% | -$2.2M | 0.01% | 888 |
|
|
2024
Q4 | $20.3M | Buy |
248,034
+39,159
| +19% | +$3.21M | 0.02% | 649 |
|
|
2024
Q3 | $23.9M | Buy |
208,875
+49,863
| +31% | +$5.7M | 0.03% | 625 |
|
|
2024
Q2 | $12M | Buy |
+159,012
| New | +$12M | 0.01% | 777 |
|
|
2022
Q4 | – | Hold |
0
| – | -$22K | – | 2189 |
|
|
2022
Q3 | – | Sell |
-928
| Closed | -$20K | – | 2164 |
|
|
2022
Q2 | $20K | Hold |
928
| – | – | ﹤0.01% | 2309 |
|
|
2022
Q1 | $22 | Hold |
928
| – | – | ﹤0.01% | 2363 |
|
|
2021
Q4 | $22K | Sell |
928
-1,064
| -53% | -$25.2K | ﹤0.01% | 2374 |
|
|
2021
Q3 | $51K | Hold |
1,992
| – | – | ﹤0.01% | 2227 |
|
|
2021
Q2 | $45K | Buy |
+1,992
| New | +$45K | ﹤0.01% | 2178 |
|